Last reviewed · How we verify
Indigo (INDIGO)
Unfortunately, the mechanism of action of Indigo is unknown.
Indigo is a small molecule drug developed by Hahnemann Laboratories, INC. and currently owned by Provepharm Sas. Unfortunately, there is limited information available on its target, drug class, and approved indications. As a result, its mechanism of action, safety considerations, and commercial status are unclear. Further research is needed to determine its potential therapeutic applications and risks.
At a glance
| Generic name | INDIGO |
|---|---|
| Sponsor | Provepharm Sas |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Mechanism of action
This means that we don't know how it works at a basic level to help the body. In general, medications work by interacting with specific molecules or systems in the body to produce a desired effect. Without this information, it's difficult to understand how Indigo might help patients.
Approved indications
- Visualization of the ureteral orifices
Common side effects
Key clinical trials
- Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy (NA)
- A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
- Clinical Trial to Evaluate the Efficacy and Safety of SUBMO® as a Submucosal Injection Agent in Endoscopic Resection of Superficial Gastrointestinal Lesions. (NA)
- BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis (NA)
- Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
- A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease (PHASE3)
- Post Market Surveillance to Evaluate the Efficacy and Safety of the INDIGO Aspiration System in Japan
- Indigotindisulfonate Sodium as an Aid in Determination of Ureteral Patency in Patient's With Renal Impairment (PHASE4)
Patents
| Patent | Expiry | Type |
|---|---|---|
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
| FDA Orange Book | Patents + exclusivity |